Cargando…

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?

Background: Dexamethasone and tocilizumab are used to treat severely ill COVID-19 patients admitted to intensive care units (ICUs). We explored whether combination therapy increased the risk of superinfection compared to dexamethasone alone. Methods: This observational, retrospective study included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camou, Fabrice, Issa, Nahéma, Hessamfar, Mojgan, Guisset, Olivier, Mourissoux, Gaëlle, Pedeboscq, Stéphane, Minot, Aimée, Bonnet, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573530/ https://www.ncbi.nlm.nih.gov/pubmed/36233432 http://dx.doi.org/10.3390/jcm11195559

Ejemplares similares

L'association tocilizumab et dexaméthasone au cours du COVID-19 sévère est-elle associée à un risque de surinfection ?
por: Camou, F., et al.
Publicado: (2022)

Contribution of the qPCR for the Diagnosis of Pneumocystosis
por: Issa, Nahema, et al.
Publicado: (2017)

Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis
por: Mottal, Nathan, et al.
Publicado: (2020)

Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?
por: Saunier, Aurélie, et al.
Publicado: (2017)

Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019
por: Rubin, Sébastien, et al.
Publicado: (2020)

Faisabilité de la transfusion de plasma de donneurs convalescents pour COVID-19 en réanimation
por: Camou, Fabrice, et al.
Publicado: (2021)

CMR and serology to diagnose COVID-19 infection with primary cardiac involvement
por: Gravinay, Pierre, et al.
Publicado: (2020)

1076. What Is the Positivity Delay of Blood Cultures in Infective Endocarditis?
por: Issa, Nahema, et al.
Publicado: (2018)

1086. Impact of Systematic Thoraco-Abdomino-Pelvic CT Scan on the Diagnosis of Infective Endocarditis
por: Lecomte, Raphaël, et al.
Publicado: (2018)

1083. Long-Term Prognosis of 448 Infectious Endocarditis Followed by an Endocarditis Team
por: Camou, Fabrice, et al.
Publicado: (2018)

Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020)

Tocilizumab: Elevated liver enzyme levels, superinfections and thrombocytopenia: 15 case reports
Publicado: (2021)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)
por: Fleury, Hervé, et al.
Publicado: (2020)

High-resolution Free-breathing late gadolinium enhancement Cardiovascular magnetic resonance to diagnose myocardial injuries following COVID-19 infection
por: Bustin, Aurélien, et al.
Publicado: (2021)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
por: Hermine, Olivier, et al.
Publicado: (2022)

Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV)
por: Devos, Sophie, et al.
Publicado: (2023)

Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018–2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)
por: Barger, Diana, et al.
Publicado: (2023)

Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
por: Barger, Diana, et al.
Publicado: (2020)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Food-borne botulism outbreak during the Rugby World Cup linked to marinated sardines in Bordeaux, France, September 2023
por: Courtot-Melciolle, Léa, et al.
Publicado: (2023)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients
por: Frulio, Nora, et al.
Publicado: (2014)

A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population
por: Hémar, Victor, et al.
Publicado: (2022)

Dexamethasone/prednisone/tocilizumab: Worsening of Strongyloides infection: case report
Publicado: (2020)

Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
por: Rashad, Alaa, et al.
Publicado: (2021)

Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort
por: Hessamfar, Mojgan, et al.
Publicado: (2014)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

Retroviral superinfection resistance
por: Nethe, Micha, et al.
Publicado: (2005)

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
por: Hong, Jin Yeong, et al.
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients
por: Signorini, Liana, et al.
Publicado: (2021)

PREDICTORS AND OUTCOMES OF BACTERIAL AND FUNGAL SUPERINFECTIONS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: YAQOOB, HAMID, et al.
Publicado: (2021)

Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19
por: Yoon, Si Mong, et al.
Publicado: (2023)

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ofth6ore09fjm1oe1jssk0slo1